Cutaneous adverse effects associated with LAG‐3 inhibitor use in cancer treatment: A systematic review

• Main Authors: Hira Ghani (Author), Samavia Khan (Author), Marielle Jamgochian (Author), Beth Richards (Author), Erica DeCecco (Author), Rebecca Fliorent (Author), Nithisha Cheendalla (Author), Khalil Khatri (Author), Babar Rao (Author)
• Formato: Livro
• Publicado em: Wiley, 2023-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Immunotherapy has become a mainstay of treatment for many cancers. Multiple immune checkpoint inhibitors have been used to treat malignancies, including anti‐programed death‐1 (PD1) and anti‐cytotoxic T‐lymphocyte‐associated protein (anti‐CTLA4). However, a significant percentage of patient...